Sickle Cell Disease Global Clinical Trials Review, H2, 2014

Date: August 20, 2014
Pages: 102
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S76CBA33E7EEN
Leaflet:

Download PDF Leaflet

Summary

GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H2, 2014' provides data on the Sickle Cell Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sickle Cell Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sickle Cell Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note:: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Sickle Cell Disease
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Sickle Cell Disease
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Sickle Cell Disease Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Sickle Cell Disease
Jun 16, 2014: Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC Trial
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Novartis AG
Clinical Trial Overview of Novartis AG
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Prolong Pharmaceuticals
Clinical Trial Overview of Prolong Pharmaceuticals
HemaQuest Pharmaceuticals, Inc.
Clinical Trial Overview of HemaQuest Pharmaceuticals, Inc.
Selexys Pharmaceuticals Corporation
Clinical Trial Overview of Selexys Pharmaceuticals Corporation
Ikaria Inc.
Clinical Trial Overview of Ikaria Inc.
Emmaus Life Sciences, Inc.
Clinical Trial Overview of Emmaus Life Sciences, Inc.
Baxter International Inc.
Clinical Trial Overview of Baxter International Inc.
Clinical Trial Overview of Top Institutes / Government
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
HaEmek Medical Center
Clinical Trial Overview of HaEmek Medical Center
Cincinnati Children's Hospital Medical Center
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center
Duke University
Clinical Trial Overview of Duke University
Emory University
Clinical Trial Overview of Emory University
National Institutes of Health Clinical Center
Clinical Trial Overview of National Institutes of Health Clinical Center
Baylor College of Medicine
Clinical Trial Overview of Baylor College of Medicine
Children's Hospital & Research Center Oakland
Clinical Trial Overview of Children's Hospital & Research Center Oakland
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Region, 2014*
Sickle Cell Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, North America, Top Countries, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Phase, 2014*
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014*
Sickle Cell Disease Therapeutics, Global, Suspended Clinical Trials, 2014*
Sickle Cell Disease Therapeutics, Global, Withdrawn Clinical Trials, 2014*
Sickle Cell Disease Therapeutics, Global, Terminated Clinical Trials, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Sickle Cell Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
Sickle Cell Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Prolong Pharmaceuticals, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by HemaQuest Pharmaceuticals, Inc., 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Selexys Pharmaceuticals Corporation, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Inc., 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Emmaus Life Sciences, Inc., 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014*
Sickle Cell Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital & Research Center Oakland, 2014*

LIST OF FIGURES

Sickle Cell Disease Therapeutics, Global, Clinical Trials by Region (%), 2014
Sickle Cell Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Sickle Cell Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Sickle Cell Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Sickle Cell Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Sickle Cell Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014
Sickle Cell Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, G7 Countries (%), 2014
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Sickle Cell Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Sickle Cell Disease to Hematological Disorders Clinical Trials, E7 Countries (%), 2014
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Sickle Cell Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014
Sickle Cell Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Sickle Cell Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014
Sickle Cell Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014
Sickle Cell Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Sickle Cell Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Sickle Cell Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Sickle Cell Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Sickle Cell Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Sickle Cell Disease - Pipeline Review, H2 2016 US$ 2,000.00 Oct, 2016 · 199 pages

Ask Your Question

Sickle Cell Disease Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: